Reporting on circulating tumor DNA monitoring in metastatic cancer: -From clinical validity to clinical utility

Caroline Brenner Thomsen, Amanda Dandanell Juul, Anna Cecilie Lefèvre, Christina Glismand Truelsen, Edina Dizdarevic, Heidi Ryssel, Ina Mathilde Kjaer, Karen Lycke Wind, Louise Bach Callesen, Louise Faaborg Larsen, Malene Støchkel Frank, Rikke Fredslund Andersen, Karen-Lise Garm Spindler, Anders Jakobsen

12 Citations (Scopus)

Abstract

This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors.
Original languageEnglish
JournalCancer
Volume128
Issue number11
Pages (from-to)2052-2057
Number of pages6
ISSN0008-543X
DOIs
Publication statusPublished - 1 Jun 2022

Keywords

  • Biomarkers, Tumor/genetics
  • Circulating Tumor DNA/genetics
  • Humans
  • Mutation
  • Neoplasms/genetics
  • Neoplasms, Second Primary
  • reporting on circulating tumor DNA
  • clinical utility
  • standardization
  • metastatic cancer
  • circulating tumor DNA (ctDNA)
  • monitoring

Fingerprint

Dive into the research topics of 'Reporting on circulating tumor DNA monitoring in metastatic cancer: -From clinical validity to clinical utility'. Together they form a unique fingerprint.

Cite this